Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation Associated With Postoperative Transhepatic Arterial Chemoembolization——a Prospective Randomized Clinical Trial
A randomized study was conducted to elucidate whether the outcome of hepatocellular
carcinoma could be improved by radiofrequency ablation associated with postoperative
transhepatic arterial chemoembolization.
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
disease free survival
3 years
No
Ma Kuansheng, Ph.D
Study Director
Institute of hepatobiliary surgery,Southwest Hospital
China: Ethics Committee
SWHB002
NCT00730860
December 2008
July 2013
Name | Location |
---|